Zobrazeno 1 - 10
of 325
pro vyhledávání: '"David C, Ward"'
Autor:
Nicole Urban, Claire S. Zhu, Zhen Zhang, David C. Ward, Sudhir Srivastava, Patrick M. Sluss, Steven J. Skates, Nathalie Scholler, Mark D. Thornquist, Paul F. Pinsky, Christos Patriotis, Gil Mor, Martin W. McIntosh, Karen H. Lu, Anna E. Lokshin, Patricia Hartge, Andrew K. Godwin, Eleftherios P. Diamandis, Christine D. Berg, Robert C. Bast, Daniel W. Cramer
Establishing a cancer screening biomarker's intended performance requires “phase III” specimens obtained in asymptomatic individuals before clinical diagnosis rather than “phase II” specimens obtained from symptomatic individuals at diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf1e70b162e8cd9fbba21a5004249ba5
https://doi.org/10.1158/1940-6207.c.6544857
https://doi.org/10.1158/1940-6207.c.6544857
Autor:
Nicole Urban, Claire S. Zhu, Zhen Zhang, David C. Ward, Sudhir Srivastava, Patrick M. Sluss, Steven J. Skates, Nathalie Scholler, Mark D. Thornquist, Paul F. Pinsky, Christos Patriotis, Gil Mor, Martin W. McIntosh, Karen H. Lu, Anna E. Lokshin, Patricia Hartge, Andrew K. Godwin, Eleftherios P. Diamandis, Christine D. Berg, Robert C. Bast, Daniel W. Cramer
Perspectives on This Article from Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0327c80f36bfd0572b80a18ce723774d
https://doi.org/10.1158/1940-6207.22525686.v1
https://doi.org/10.1158/1940-6207.22525686.v1
Autor:
Christine D. Berg, Saundra S. Buys, Sudhir Srivastava, Christos Patriotis, Adele M. Marrangoni, Karen H. Lu, Nathalie Scholler, Patrick M. Sluss, Eric T. Fung, Aleksey Lomakin, James T. Symanowski, David C. Ward, Zhen Zhang, Allison Vitonis, Steven J. Skates, Martin W. McIntosh, Anna E. Lokshin, Lee E. Moore, Robert C. Bast, Gil Mor, Nicole Urban, Ruth M. Pfeiffer, Patricia Hartge, David F. Ransohoff, Daniel W. Cramer, Paul F. Pinsky, Claire S. Zhu
A panel of biomarkers may improve predictive performance over individual markers. Although many biomarker panels have been described for ovarian cancer, few studies used prediagnostic samples to assess the potential of the panels for early detection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5efdfd15abacb677fe17610c36b679fb
https://doi.org/10.1158/1940-6207.c.6544599
https://doi.org/10.1158/1940-6207.c.6544599
Autor:
Christine D. Berg, Saundra S. Buys, Sudhir Srivastava, Christos Patriotis, Adele M. Marrangoni, Karen H. Lu, Nathalie Scholler, Patrick M. Sluss, Eric T. Fung, Aleksey Lomakin, James T. Symanowski, David C. Ward, Zhen Zhang, Allison Vitonis, Steven J. Skates, Martin W. McIntosh, Anna E. Lokshin, Lee E. Moore, Robert C. Bast, Gil Mor, Nicole Urban, Ruth M. Pfeiffer, Patricia Hartge, David F. Ransohoff, Daniel W. Cramer, Paul F. Pinsky, Claire S. Zhu
Perspectives on This Article from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef42eb78d3a5eef0b36c34e0a3de94b
https://doi.org/10.1158/1940-6207.22525149
https://doi.org/10.1158/1940-6207.22525149
Autor:
Christine D. Berg, Saundra S. Buys, Sudhir Srivastava, Christos Patriotis, Adele M. Marrangoni, Karen H. Lu, Nathalie Scholler, Patrick M. Sluss, Eric T. Fung, Aleksey Lomakin, James T. Symanowski, David C. Ward, Zhen Zhang, Allison Vitonis, Steven J. Skates, Martin W. McIntosh, Anna E. Lokshin, Lee E. Moore, Robert C. Bast, Gil Mor, Nicole Urban, Ruth M. Pfeiffer, Patricia Hartge, David F. Ransohoff, Daniel W. Cramer, Paul F. Pinsky, Claire S. Zhu
Supplementary Materials from A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::331c0cc2086b8e679b5458911c6cfcac
https://doi.org/10.1158/1940-6207.22525146.v1
https://doi.org/10.1158/1940-6207.22525146.v1
Autor:
Gil Mor, Peter E. Schwartz, Thomas Rutherford, Masoud Azori, Herbert Yu, Ruben Flores-Saaib, Aliza Leiser, Jeannette Tenthorey, Yinglei Lai, Ayesha B. Alvero, David C. Ward, Gary Longton, Ziding Feng, Irene Visintin
{Supplementary Data} from Diagnostic Markers for Early Detection of Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0805f3529e281003dab0895ca9649073
https://doi.org/10.1158/1078-0432.22439605.v1
https://doi.org/10.1158/1078-0432.22439605.v1
Autor:
Gil Mor, Peter E. Schwartz, Thomas Rutherford, Masoud Azori, Herbert Yu, Ruben Flores-Saaib, Aliza Leiser, Jeannette Tenthorey, Yinglei Lai, Ayesha B. Alvero, David C. Ward, Gary Longton, Ziding Feng, Irene Visintin
Purpose: Early detection would significantly decrease the mortality rate of ovarian cancer. In this study, we characterize and validate the combination of six serum biomarkers that discriminate between disease-free and ovarian cancer patients with hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a47deb57c0f5e9b1aef1e69ea695931
https://doi.org/10.1158/1078-0432.c.6517045.v1
https://doi.org/10.1158/1078-0432.c.6517045.v1
Autor:
Gil Mor, Peter E. Schwartz, Thomas Rutherford, Masoud Azori, Herbert Yu, Ruben Flores-Saaib, Aliza Leiser, Jeannette Tenthorey, Yinglei Lai, Ayesha B. Alvero, David C. Ward, Gary Longton, Ziding Feng, Irene Visintin
Correction: Clin Cancer Res 2008 14: 1065-1072 from Diagnostic Markers for Early Detection of Ovarian Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103163a2a26fe77132e9fc10df00d651
https://doi.org/10.1158/1078-0432.22439608
https://doi.org/10.1158/1078-0432.22439608
Autor:
Anthony R Torres, Thayne L Sweeten, Randall C Johnson, Dennis Odell, Jonna B Westover, Patricia Bray-Ward, David C Ward, Christopher J Davies, Aaron J Thomas, Lisa A Croen, Michael Benson
Publikováno v:
Frontiers in Neuroscience, Vol 10 (2016)
The common variant - common disease hypothesis was proposed to explain diseases with strong inheritance. This model suggests that a genetic disease is the result of the combination of several common genetic variants. Common genetic variants are descr
Externí odkaz:
https://doaj.org/article/0857e46ea5f5427fa1293fe9c3717fb4
Autor:
David C. Ward, Fu Gang Duan, Ying Xie, Zhongqiu Liu, Liang Liu, Elaine Lai-Han Leung, Dan Feng Shi, Jian Ding, Xiao Jun Yao, Lan Lan Li, Lin Lin Lu, Min Huang, Xing Xing Fan, Lian Xiang Luo, Zhong Wen Yuan, Ying Li, Ju-Min Huang
Publikováno v:
International Journal of Cancer. 145:1334-1345
Oncogenic KRAS is considered a promising target for anti-cancer therapy. However, direct pharmacological strategies targeting KRAS-driven cancers remained unavailable. The prenyl-binding protein PDEδ, a transporter of KRAS, has been identified as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5e31792f8aee436fa9d38af4de7e4d6
https://doi.org/10.1002/ijc.32222
https://doi.org/10.1002/ijc.32222